Effect of acceptance and commitment therapy on diabetic neuropathy

A study of effectiveness of acceptance and commitment therapy on improving psychopathological symptoms of patients with diabetic neuropathy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180205038630N4

Enrollment

Registered

2019-04-05

Start date

2019-04-21

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic neuropathy. Other specified diabetes mellitus with diabetic neuropathy, unspecified

Interventions

Intervention 1: Intervention group: Individuals receive acceptance and commitment therapy in addition to anti-pain medication for eight weeks. After the treatment is completed, the post test will be t

Eligibility

Sex/Gender

All

Age

35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis of diabetic neuropathy by a neurologist willingness to participate in the research Age range 35 to 65 years old Having at least eighth school grade

Exclusion criteria

Exclusion criteria: Drug abuse Concurrent participation in other therapeutic plan Having any somatization disorder

Design outcomes

Primary

Measure	Time frame
Score in Acceptance Chronic Pain Questionnaire. Timepoint: At the beginning of the study, after the study (after the end of the intervention) and two months after the study. Method of measurement: Acceptance chronic pain Questionnaire.;Score in McGill Pain Revised Questionnaire. Timepoint: At the beginning of the study, after the study (after the end of the intervention) and two months after the study. Method of measurement: McGill Pain Revised Questionnaire.;Score in Self-Compassion Scale (Short Form). Timepoint: At the beginning of the study, after the study (after the end of the intervention) and two months after the study. Method of measurement: Self-Compassion Scale.;Score in Sleep Quality Inventory. Timepoint: At the beginning of the study, after the study (after the end of the intervention) and two months after the study. Method of measurement: Sleep Quality Inventory.;Score in Occupational and Social Adjustment Scale. Timepoint: At the beginning of the study, after the study (after the end of the intervention) and two months after the study. Method of measurement: Occupational and Social Adjustment Scale.	—

Measure

Time frame

Score in Acceptance Chronic Pain Questionnaire. Timepoint: At the beginning of the study, after the study (after the end of the intervention) and two months after the study. Method of measurement: Acceptance chronic pain Questionnaire.;Score in McGill Pain Revised Questionnaire. Timepoint: At the beginning of the study, after the study (after the end of the intervention) and two months after the study. Method of measurement: McGill Pain Revised Questionnaire.;Score in Self-Compassion Scale (Short Form). Timepoint: At the beginning of the study, after the study (after the end of the intervention) and two months after the study. Method of measurement: Self-Compassion Scale.;Score in Sleep Quality Inventory. Timepoint: At the beginning of the study, after the study (after the end of the intervention) and two months after the study. Method of measurement: Sleep Quality Inventory.;Score in Occupational and Social Adjustment Scale. Timepoint: At the beginning of the study, after the study (after the end of the intervention) and two months after the study. Method of measurement: Occupational and Social Adjustment Scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Abbas Taheri

Kermanshah University of Medical Sciences

taheriamir679@gmail.com+98 31 5322 6077

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 27, 2026